A cost-effective, high-throughput genotyping method for plant breeding that uses shallow genome sequencing and haplotype-based imputation to accurately characterize genetic variants. Developed at Georg-August-Universität Göttingen, the technique replaces expensive array-based markers with a more flexible, scalable approach that is already in commercial use.
This genotyping method, developed by researchers at Georg-August-Universität Göttingen, provides a cost-effective and efficient solution for plant breeding and research. By leveraging software-assisted imputation based on haplotype libraries, the technology enables high-throughput, accurate analysis of genetic variants. It is designed to replace traditional array-based genotyping, which is often limited by higher costs and lack of flexibility. The method has already been implemented in breeding programs, demonstrating its practical utility in improving selection reliability for complex traits such as yield and pest resistance.
The technology is at level 8. It has been validated through research publications and is currently in use within commercial breeding programs, such as those conducted by KWS SAAT SE & Co. KGaA. Patent protection has been granted in the United States and is pending in other jurisdictions, reflecting its maturity and transition to commercial application.
Georg‑August‑Universität Göttingen is a comprehensive public research university in Lower Saxony with broad academic breadth and a major university medical center. Through the Göttingen Campus alliance, the university is co‑located with Max Planck and Leibniz institutes, supported by a shared research data center that links campus partners and services. Clinical translation is enabled by the University Medical Center Göttingen, while proximity to leading life‑science and precision‑measurement companies in the region supports applied collaboration and talent pipelines. The university’s research is supported by competitive funding from the German Research Foundation, federal ministries, and European programmes. Technology transfer is provided by MBM ScienceBridge, a wholly owned subsidiary that manages IP, licensing, and startup support.